Anemia :: Roche suspends enrollment for anemia drug trial
Roche announced that it is temporarily suspending recruitment into its Phase II dose-finding study (NH19960) with the investigational drug C.E.R.A. in anaemic patients with advanced non small cell lung cancer receiving chemotherapy.